<--- Back to Details
First PageDocument Content
Gilead Sciences / Tenofovir alafenamide / Tenofovir disoproxil / Emtricitabine / Gilead / Fixed-dose combination
Date: 2016-03-02 13:23:14
Gilead Sciences
Tenofovir alafenamide
Tenofovir disoproxil
Emtricitabine
Gilead
Fixed-dose combination

Microsoft Word - GOCER-028.docx

Add to Reading List

Source URL: www.gilead.com

Download Document from Source Website

File Size: 18,94 KB

Share Document on Facebook

Similar Documents

67 Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate Wai-Kay Seto2, Yasuhiro Asahina3, Cheng-Yuan Peng4, Carol Stanciu5, Djamal Abdur

DocID: 1timf - View Document

ABSTRACT FINAL ID: LB-7 TITLE: Preliminary safety and efficacy of REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated interferon alpha 2a in treatment naïve Caucasian patients

DocID: 1sU8R - View Document

PrEPARING FOR THE END OF HIV? How to access PrEP in Contra Costa County… For Insured Folks: Private Medical Provider-Most health insurance companies cover Truvada (emtricitabine and tenofovir disoproxil fumarate, the m

DocID: 1rAVd - View Document

Gilead Sciences / Chemistry / HIV/AIDS / Medicine / Organofluorides / Specialty drugs / Prodrugs / Prevention of HIV/AIDS / AIDS Healthcare Foundation / Tenofovir alafenamide / Tenofovir disoproxil / Fixed-dose combination

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Business / Economy / Health care / Gilead Sciences / Specialty drugs / Pharmaceuticals policy / Tenofovir alafenamide / Valeant Pharmaceuticals / Tenofovir disoproxil / Rilpivirine / Pharmaceutical industry in China / AstraZeneca

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document